First characterization of a Providencia stuartii clinical isolate from a Tunisian intensive care unit coproducing VEB-1-a, OXA-2, qnrA6 and aac(6')-Ib-cr determinants

Brazilian Journal of Infectious Diseases

Volumn 18, Issue 2, 2014, Pages 211-214

  Mahrouki, Sihem ^a   Chihi, Hela ^a   Bourouis, Amel ^a   Ben Moussa, Mohamed ^b   Belhadj, Omrane ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

Aac(6') Ib cr; ESBL; Providencia stuartii; QnrA6

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; AMOXICILLIN; BETA LACTAMASE TEM 1; CEFEPIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; OFLOXACIN; OXA 2 LIKE EXTENDED SPECTRUM BETA LACTAMASE; OXACILLIN; PIPERACILLIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG; VEB 1 A EXTENDED SPECTRUM BETA LACTAMASE;

AAC(6') IB CR GENE; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE REPORT; CODON; ELECTROPORATION; GENE MUTATION; GYRA GENE; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; ISOELECTRIC FOCUSING; MALE; MIDDLE AGED; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXA GENE; POLYMERASE CHAIN REACTION; PROVIDENCIA STUARTII; QNRA6 GENE; TUNISIA; VEB 1 A GENE; AAC 6 IB CR GENE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM DETECTION; BACTERIUM EXAMINATION; BLAOXA 2 LIKE GENE; BLAVEB 1 GENE; CHROMOSOMAL LOCALIZATION; DIABETES MELLITUS; DRUG POTENTIATION; DRUG TREATMENT FAILURE; EPILEPSY; FEVER; GENE STRUCTURE; GENE TRANSFER; HYBRIDIZATION; INTEGRON; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; RE ELEMENT; URINARY TRACT INFECTION;

AAC(6′)-IB-CR; ESBL; PROVIDENCIA STUARTII; QNRA6;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROVIDENCIA; TUNISIA;

EID: 84897667911     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2013.10.004     Document Type: Article

References (20)

1. Aubert D., Naas T., Lartigue M.F., Nordmann P. Novel genetic structure associated with an extended-spectrum β-lactamase blaVEB gene in a Providencia stuartii clinical isolate from Algeria. Antimicrob Agents Chemother 2005, 49:3590-3592.
2. Franceschini N., Perilli M., Segatore B., et al. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended spectrum β-lactamase, TEM-60. Antimicrob Agents Chemother 1998, 42:1459-1462.
3. Naas T., Benaoudia F., Massuard S., Nordmann P. Integron located VEB-1 extended-spectrum β-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J Antimicrob Chemother 2000, 46:703-711.
4. Ktari S., Mnif B., Znazen A., et al. Diversity of β-lactamases in Pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals. Microb Drug Resist 2011, 17:25-30.
5. CMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a tunisian burn unit. Antimicrob Agents Chemother 2012, 56:1342-1349.
6. Mahrouki S., Chihi H., Bourouis A., Ben-Moussa M., Barguellil F., Belhadj O. First characterisation in Tunisia of plasmid mediated AmpC bêta-lactamase DHA-1 coexpressed TEM-24 and qnrA6 in a multidrug resistant Proteus mirabilis clinical strain. Afr J Microb Res 2011, 5:3913-3918.
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. 20th Informational Supplement M100-S20 2007, Clinical and Laboratory Standards Institute, Wayne, Penn.
8. Livermore D.M., Brown D.F.J. Detection of β-lactamase-mediated resistance. J Antimicrob Chemother 2001, 48:59-64.
9. Kim J.Y., Park Y.J., Kim S.I., Kang M.Y., Lee S.O., Lee K.Y. Nosocomial outbreak by Proteus mirabilis producing extended spectrum β-lactamase VEB-1 in a Korean University Hospital. J Antimicrob Chemother 2004, 54:1144-1147.
10. De Champs C., Poirel L., Bonnet R., et al. Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French Hospital in 2000. Antimicrob Agents Chemother 2002, 46:3031-3034.
11. Bourouis A., Dubois V., Coulange L., et al. First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian Hospital. Pathol Biol 2011, 59:187-191.
12. Pérez-Pérez F.J., Hanson N.D. Detection of plasmid-mediated AmpC β-lactamases genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002, 40:2153-2162.
13. Naas T., Poirel L., Karim A., Nordmann P. Molecular characterization of In50, a class 1 integron encoding the gene for the extended-spectrum β-lactamase VEB-1 in Pseudomonas aeruginosa. FEMS Microbiol Lett 1999, 176:411-419.
14. Aubert D., Girlich D., Naas T., Nagarajan S., Nordmann P. Functional and structural characterization of the genetic environment of an extended-spectrum β-lactamase blaVEB gene from a Pseudomonas aeruginosa isolate obtained in India. Antimicrob Agents Chemother 2004, 48:3284-3290.
15. Mahrouki S., Ben Achour N., Chouchani C., Ben Moussa M., Belhadj O. Identification of plasmid-encoded extended spectrum β-lactamases produced by a clinical strain of Proteus mirabilis. Pathol Biol 2009, 57:e55-e59.
16. Sambrook J., MacCallum P., Russell D. Molecular cloning: a laboratory manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. 3rd ed.
17. Aibinu I.E., Pfeifer Y., Ogunsola F., Odugbemi T., Koenig W., Ghebremedhin B. Emergence of β-lactamases OXA-10, VEB-1 and CMY in Providencia spp. from Nigeria. J Antimicrob Chemother 2011, 1931-1932. 10.1093/jac/dkr197.
18. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
19. Perilli M., Forcella C., Celenza G., et al. Evidence for qnrB1 and aac(6')-Ib-cr in CTX-M-15-producing uropathogenic Enterobacteriaceae in an Italian teaching hospital. Diagn Microbiol Infect Dis 2009, 64:90-93.
20. Mammeri H., Van De Loo M., Poirel L., Martinez-Martinez L., Nordmann P. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 2005, 49:71-76.